132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation
132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does 132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation have?
132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation has 2 citations in the OpenAlex counts ScholarIQ stores.
When was 132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation published?
132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation has 2012 year in the ScholarIQ index.
What is the open-access status of 132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation?
132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation has closed oa status in the ScholarIQ index.
What is the DOI of 132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation?
The DOI for 132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation is on the source record.
What is the OpenAlex record for 132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation?
The OpenAlex for 132 Epithelial to Mesenchymal Transition Leads to Crizotinib-resistance in H2228 Lung Cancer Cells with EML4-ALK Translocation is on the source record.